We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 6.40 | 6.20 | 7.00 | - | 191,136 | 15:22:53 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.73 | 12.89M |
Date | Subject | Author | Discuss |
---|---|---|---|
21/3/2020 22:33 | >> dave Yes probably more hopeful than the reality. As long as I can get 1000... I may well buy some by spreadbet too although annoyingly Spreadex had them as phone only trade most of Friday! | nobbygnome | |
21/3/2020 22:24 | What on Earth do you gain by knocking ncyt yeti? I choose to post what I hope is informative comments on companies with diagnostics, therapeutics and vaccines. I don’t have the time to post everywhere so just use the ncyt board. We are all in this together. Like bounty and hazl I am also substantially invested here. I am also invested in in TILS that has a MoAb aiming like SNG to reduce the potentially lethal lung toxicity of Covid-19. Role back through my posts to see my thoughts on, for example, Gilead and Moderna. The enemy is Covid-19, not ncyt investors. | freedosh | |
21/3/2020 22:23 | Can I call u Leonard (bbt) | yet another final | |
21/3/2020 22:22 | Btw I value any posters input which provides snippets of useful information.I have yet to read any valuable post from bounty in the past few months. In fact his post on this thread was purely to promote another share, and add no value to the readers.My apologies, I rant, but any newcomer to this thread would be distracted by irrelevant name dropping (told u this would happen. Final words said! | yet another final | |
21/3/2020 22:21 | Thanks Nobby. Think you're 50p opening gambit on Monday is a bit optimistic (for your moneybox money) though agreed £1 is probably overly optimistic for now. However the amount now riding on this is huge given the deaths and the money being thrown now to rescue virtually all economies, businesses, jobs, livelihoods, homes and so many lives. | davew28 | |
21/3/2020 22:19 | Thanks for the protocol posting, | lukead | |
21/3/2020 22:17 | As I have said before, I have no problem with reasoned negative views. However, trolling or endless repetition of the same negative view will not be tolerated! Oh the power... | nobbygnome | |
21/3/2020 22:15 | Thank you NobbyI have been openly critical of NCYT for several reasons (btw I owned it and sold three times making a good profit) Unfortunately Bounty has the cheek to come on here asking for me to be filtered/moderated, for pointing out deficiencies in NCYT, which he elects to dismiss rather engage in reasonable debate. Guess he must be a dictator, and how dare I speak up against the regime I am invested here and will continue to be until the 'story' changes, and the reserve the right to be critical of the company when appropriate | yet another final | |
21/3/2020 22:11 | >> Eva My guess is around £100 million (95p ish) before the trial result so about a doubling from where we are now. But of course it is really just a guess... | nobbygnome | |
21/3/2020 21:59 | >> Dave My understanding is that it is an off the shelf inhaler. Having enough supply of drug is an issue assuming the trial is positive and I would be interested to know if they are manufacturing drug at risk. Of course it will be contracted out to a third party so is not actually done by SNG. | nobbygnome | |
21/3/2020 21:58 | Fair enough, but keep an eye on him :) He is one of only a few I have had to filter on my NCYT Covid-19 thread. | bountyhunter | |
21/3/2020 21:57 | Ok he is on probation but I can't really see any reason to ban him at the moment from what he has posted here. | nobbygnome | |
21/3/2020 21:50 | Nobbygnome, I strongly suggest you add 'yet another final' to the filter as he has proved to be full of false information in his desperate deramping attempts since FDA EUA Approval of Novacyt's Covid-19 tests yesterday on the Novacyt thread. No doubt he will end up doing the same here if not already, a real charlatan if ever I have seen one. I have had to filter him although others remain who have sensible and honest views positive or negative. Unfortunately judging by posting style and content I have no doubt that he has numerous aliases. Incidentally I have a link to your thread here from the top of my NCYT thread. I am invested in both. | bountyhunter | |
21/3/2020 21:49 | Will there be an adequate supply of inhalers should there be a positive result? Probably not as complex to manufacture as respirators, but does this require a unique or special one? | davew28 | |
21/3/2020 21:46 | So what are thoughts on likely market cap pre trial completion? | allstar4eva | |
21/3/2020 21:45 | Rest assured, if the trial result is positive, it will be used în an enormous number of patients worldwide! Hence the opportunity here....it could be a life changing investment! | nobbygnome | |
21/3/2020 21:44 | Thanks for that, and yes it indicates usage in non-severe infections, which is even better. | yet another final | |
21/3/2020 21:43 | So no limit on age although non hospitalised patients need to have a comorbidity. | nobbygnome | |
21/3/2020 21:42 | What the protocol says about the patient population Patients admitted to hospital due to the severity of their COVID-19 disease OR non-hospitalised patients from high-risk co-morbidity groups such as the >65-years of age, or those with hypertension, cardiovascular disease, diabetes or a chronic lung condition | nobbygnome | |
21/3/2020 21:41 | Trump is using an American company, Thermofisher... They can produce 5million tests per weekNcyt will have no chance in the usa | yet another final | |
21/3/2020 21:40 | This is the protocol... | nobbygnome | |
21/3/2020 21:39 | That's the first step... I wrote about the stages of testing and potentialIn the short term (given that time is of the essence) to get a meaningful result in a trial it is best to test in the sickest individuals, as they have most to gain | yet another final | |
21/3/2020 21:35 | So you reckon that the company thinks it can be beneficial to everyone young and old with severe or moderate conditions I wonder if you contact the virus once , can you get again and again | lukead | |
21/3/2020 21:31 | No the clinical trial protocol says patients can also be treated at home, which is key for increasing the size of the potential market. Not that doctors are going to keep the label in this sort of circumstance anyway...... | nobbygnome | |
21/3/2020 21:29 | After reading some postings, is it right that the sng drug to be tested is for in particular and primarily for those unfortunate to be hospitalised with severe symptoms or if testings successful might be of benefit to all cases and young and old? Also just on the other share Nyct, can these test kits be used in other countries apart from UK,such as Italy and USA. I suppose Trump might just want American companies used. | lukead |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions